Dose-Adjusted EPOCH With or Without Rituximab Plus Ponatinib for the Treatment of Newly-Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia/Lymphoma
University of Washington
University of Washington
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
University of Washington
M.D. Anderson Cancer Center
Medical College of Wisconsin
Dana-Farber Cancer Institute
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
City of Hope Medical Center
Children's Hospital Medical Center, Cincinnati
Masonic Cancer Center, University of Minnesota
Sanofi
Masonic Cancer Center, University of Minnesota
St. Jude Children's Research Hospital
Center for International Blood and Marrow Transplant Research
Memorial Sloan Kettering Cancer Center
University of Nebraska
M.D. Anderson Cancer Center
Alliance for Clinical Trials in Oncology
M.D. Anderson Cancer Center
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)
Washington University School of Medicine
Fred Hutchinson Cancer Center
Virginia Commonwealth University
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
University of Washington
Stanford University
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Therapeutic Advances in Childhood Leukemia Consortium
Roswell Park Cancer Institute
University of Wisconsin, Madison
University of Maryland, Baltimore
University of Maryland, Baltimore
M.D. Anderson Cancer Center